Literature DB >> 10807670

Pharmacological evaluation of the role of cyclooxygenase isoenzymes on the micturition reflex following experimental cystitis in rats.

A Lecci1, L A Birder, S Meini, R M Catalioto, M Tramontana, S Giuliani, M Criscuoli, C A Maggi.   

Abstract

Prostanoids, generated from cyclooxygenase (COX) isoenzymes, play a role in the physiological function of the lower urinary tract and are important mediators of inflammatory hyperalgesia. The present work evaluates the effects of the COX-1/COX-2 inhibitor dexketoprofen as well as of a selective COX-2 inhibitor, NS-398, on urodynamic function following endotoxin (LPS) or cyclophosphamide (CYP)-induced inflammation of the urinary bladder. The application of arachidonic acid (330 microgram rat(-1)) onto the serosal surface of the urinary bladder in control rats elicited bladder contractions which could be blocked in a dose-dependent manner by dexketoprofen (0.1 - 3 mg kg(-1), i.v.) but not by NS-398 (0.2 - 6 mg kg(-1), i.v. ). Dexketoprofen (3 mg kg(-1), i.v.) decreased the micturition frequency and increased the pressure threshold for triggering the micturition either when administered within 15 min or 3 h following surgery in control animals. NS-398 (6 mg kg(-1), i.v.) decreased the micturition frequency and increased the pressure threshold when administered 3 h but not 15 min following surgery. Administration of LPS (2 mg kg(-1), i.v., 90 - 120 min) increased both the micturition frequency and the pressure threshold for triggering the micturition reflex. Changes in urodynamic parameters induced by LPS were prevented by doses of either dexketoprofen (1 mg kg(-1), i.v.) or NS-398 (2 mg kg(-1), i.v.) which were ineffective in control animals. Pretreatment with CYP (150 mg kg(-1), i.p., 48 h) increased the micturition frequency, pressure threshold, and the minimal intravesical pressure but decreased the mean amplitude of micturition contractions. In CYP-treated rats, dexketoprofen (1 mg kg(-1), i.v.) or NS-398 (2 mg kg(-1), i.v.) blocked the CYP-induced urodynamic changes with exception of the micturition contraction amplitude. These results indicate that COX-1 may be involved in modulating the threshold for activating the micturition reflex in the normal rats and also demonstrates that inhibition of COX-2 prevents or reverses the urodynamic changes associated with bladder inflammation induced either by surgery, LPS or CYP treatments.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10807670      PMCID: PMC1572070          DOI: 10.1038/sj.bjp.0703309

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  42 in total

Review 1.  Pharmacology of lower urinary tract smooth muscles and penile erectile tissues.

Authors:  K E Anderson
Journal:  Pharmacol Rev       Date:  1993-09       Impact factor: 25.468

2.  Cyclophosphamide cystitis in rats: involvement of capsaicin-sensitive primary afferents.

Authors:  C A Maggi; A Lecci; P Santicioli; E Del Bianco; S Giuliani
Journal:  J Auton Nerv Syst       Date:  1992-05-15

3.  Characterization of the capsaicin-sensitive component of cyclophosphamide-induced inflammation in the rat urinary bladder.

Authors:  A Ahluwalia; C A Maggi; P Santicioli; A Lecci; S Giuliani
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

4.  NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions.

Authors:  N Futaki; K Yoshikawa; Y Hamasaka; I Arai; S Higuchi; H Iizuka; S Otomo
Journal:  Gen Pharmacol       Date:  1993-01

5.  Prostaglandin E2-induced bladder hyperactivity in normal, conscious rats: involvement of tachykinins?

Authors:  O Ishizuka; A Mattiasson; K E Andersson
Journal:  J Urol       Date:  1995-06       Impact factor: 7.450

6.  Prostanoids modulate reflex micturition by acting through capsaicin-sensitive afferents.

Authors:  C A Maggi; S Giuliani; B Conte; M Furio; P Santicioli; P Meli; L Gragnani; A Meli
Journal:  Eur J Pharmacol       Date:  1988-01-12       Impact factor: 4.432

Review 7.  Prostanoids as local modulators of reflex micturition.

Authors:  C A Maggi
Journal:  Pharmacol Res       Date:  1992-01       Impact factor: 7.658

8.  Effects of various drugs on bladder function in conscious rats.

Authors:  K Morikawa; M Ichihashi; M Kakiuchi; T Yamauchi; H Kato; Y Ito; Y Gomi
Journal:  Jpn J Pharmacol       Date:  1989-08

9.  Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase.

Authors:  J A Mitchell; P Akarasereenont; C Thiemermann; R J Flower; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

10.  NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro.

Authors:  N Futaki; S Takahashi; M Yokoyama; I Arai; S Higuchi; S Otomo
Journal:  Prostaglandins       Date:  1994-01
View more
  9 in total

1.  Dual, but not selective, COX-1 and COX-2 inhibitors, attenuate acetic acid-evoked bladder irritation in the anaesthetised female cat.

Authors:  Alexandra Wibberley; Gerald P McCafferty; Christopher Evans; Richard M Edwards; J Paul Hieble
Journal:  Br J Pharmacol       Date:  2006-05       Impact factor: 8.739

2.  Hypoactivity of rat detrusor muscle in a model of cystitis: exacerbation by non-selective COX inhibitors and amelioration by a selective DP1 receptor antagonist.

Authors:  Wesam Bassiouni; Tahia Daabees; Xavier Norel; Amira M Senbel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-12-14       Impact factor: 3.000

Review 3.  The role of prostanoids in urinary bladder physiology.

Authors:  Mohammad S Rahnama'i; Philip E V van Kerrebroeck; Stefan G de Wachter; Gommert A van Koeveringe
Journal:  Nat Rev Urol       Date:  2012-03-13       Impact factor: 14.432

4.  Effect of mirabegron, a novel β3-adrenoceptor agonist, on bladder function during storage phase in rats.

Authors:  Toshiki Hatanaka; Masashi Ukai; Mai Watanabe; Akiyoshi Someya; Akiyoshi Ohtake; Masanori Suzuki; Koji Ueshima; Shuichi Sato; Seiji Kaku
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-12-09       Impact factor: 3.000

5.  Protease-activated receptor-2-mediated contraction of urinary bladder is enhanced in cyclophosphamide-treated rats.

Authors:  Tsutomu Nakahara; Yuko Kubota; Maki Saito; Kenji Sakamoto; Kunio Ishii
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-12-12       Impact factor: 3.000

6.  Role of mast cells and protease-activated receptor-2 in cyclooxygenase-2 expression in urothelial cells.

Authors:  Zun-Yi Wang; Peiqing Wang; Dale E Bjorling
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-08-12       Impact factor: 3.619

Review 7.  PGE2 receptors in detrusor muscle: Drugging the undruggable for urgency.

Authors:  Ruida Hou; Ying Yu; Jianxiong Jiang
Journal:  Biochem Pharmacol       Date:  2020-12-09       Impact factor: 5.858

Review 8.  Overactive bladder syndrome and the potential role of prostaglandins and phosphodiesterases: an introduction.

Authors:  Mohammad Sajjad Rahnama'i; Gommert A Van Koeveringe; Philip E Van Kerrebroeck
Journal:  Nephrourol Mon       Date:  2013-09-10

9.  F16357, a novel protease-activated receptor 1 antagonist, improves urodynamic parameters in a rat model of interstitial cystitis.

Authors:  N Monjotin; J Gillespie; M Farrié; B Le Grand; D Junquero; N Vergnolle
Journal:  Br J Pharmacol       Date:  2016-06-03       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.